Nebenwirkungen · Ertapenem SUN
Ertapenem SUN 1 g powder for concentrate for solution for infusion · Abschnitt 4.8 · PDF-Seite 5
HOS-149727 · Präparat HOS-100112
Summary of the safety profile Adults The total number of patients treated with ertapenem in clinical studies was over 2,200 of which over 2,150 received a 1 g dose of ertapenem. Adverse reactions (i.e., considered by the investigator to be possibly, probably, or definitely related to the medicinal product) were reported in approximately 20 % of patients treated with ertapenem. Treatment was discontinued due to adverse reactions in 1.3 % of patients. An additional 476 patients received ertapenem as a single 1 g dose prior to surgery in a clinical study for the prophylaxis of surgical site infections following colorectal surgery.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-10-05T16:15:00Z · SHA-256 23ef85ab7e3d2d418a0c9d9d3bd1ae1f72006f04b4349f11c6849527e0e1bdbb · Passage 5c060a2c934d07596e55e8d9fb8e0c335385dac82cee5f8e921c9b82ffc4fee3 · Zeichen 0–635 im Abschnitt